Immucell ICCC
NASDAQ ICCC
$9.95 -0.03 (-0.30%)
At close: Sep 18, 2026 · 4:00 PM EDT

Immucell (ICCC) Net Margin Growth (3y) (2013 - 2026)

Analysis

Immucell (ICCC) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Idexx Laboratories 40.57 Bn 40.38 Bn 779.09 Mn 405.00
2 Zoetis 30.57 Bn 28.90 Bn 1.05 Bn -491.00
3 Elanco Animal Health 11.47 Bn 10.94 Bn 798.00 Mn 1,312.00
4 Phibro Animal Health 1.43 Bn 1.35 Bn 134.40 Mn 210.00
5 Immucell 87.38 Mn 78.52 Mn 2.44 Mn 6,459.00
6 Zhengye Biotechnology Holding 64.40 Mn 57.30 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6,459.00
Dec 31, 2025 -528.00
Sep 30, 2025 1,112.00
Jun 30, 2025 3,260.00
Mar 31, 2025 567.00
Dec 31, 2024 1,079.00
Sep 30, 2024 -1,454.00
Jun 30, 2024 -3,109.00
Mar 31, 2024 471.00
Sep 30, 2023 -874.00
Jun 30, 2023 -1,324.00
Mar 31, 2023 -6,468.00
Dec 31, 2022 -2,055.00
Sep 30, 2022 326.00
Jun 30, 2022 -167.00
Mar 31, 2022 898.00
Dec 31, 2021 3,763.00
Sep 30, 2021 1,447.00
Jun 30, 2021 2,959.00
Mar 31, 2021 -307.00